Serina Therapeutics to Present at HC Wainwright’s 26th Annual Global Investment Conference

HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug delivery technology, today announced that Steve Ledger, Interim Chief Executive Officer of Serina, will present at the HC Wainwright 26th Annual Global Investment Conference on September 11, 2024 at 12:00 p.m. ET.

A live webcast of the presentation can be viewed via the Investor section of Serina’s website, where an archived replay of the event will also be available for a limited time.